BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3194834)

  • 1. Neuroendocrine carcinomas of the colon and rectum: a clinicopathologic evaluation.
    Staren ED; Gould VE; Warren WH; Wool NL; Bines S; Baker J; Bonomi P; Roseman DL; Economou SG
    Surgery; 1988 Dec; 104(6):1080-9. PubMed ID: 3194834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine carcinomas of the stomach: a clinicopathologic evaluation.
    Staren ED; Lott S; Saavedra VM; Jansson DS; Deziel DJ; Saclarides TJ; Manderino GL; Gould VE
    Surgery; 1992 Dec; 112(6):1039-46; discussion 1046-7. PubMed ID: 1455307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine cancers of the colon and rectum. Results of a ten-year experience.
    Saclarides TJ; Szeluga D; Staren ED
    Dis Colon Rectum; 1994 Jul; 37(7):635-42. PubMed ID: 8026228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine carcinomas of the colon and rectum.
    Bernick PE; Klimstra DS; Shia J; Minsky B; Saltz L; Shi W; Thaler H; Guillem J; Paty P; Cohen AM; Wong WD
    Dis Colon Rectum; 2004 Feb; 47(2):163-9. PubMed ID: 15043285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine carcinoma of the colon and rectum. A clinicopathologic, ultrastructural, and immunohistochemical study of 24 cases.
    Gaffey MJ; Mills SE; Lack EE
    Am J Surg Pathol; 1990 Nov; 14(11):1010-23. PubMed ID: 2173427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Small-cell anaplastic neuroendocrine carcinoma of the rectum].
    Molas G; Bougis-de-Brux MA; Potet F
    Gastroenterol Clin Biol; 1987 Dec; 11(12):904-7. PubMed ID: 3329620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of neuroendocrine markers: a signature of human undifferentiated carcinoma of the colon and rectum.
    Grabowski P; Schönfelder J; Ahnert-Hilger G; Foss HD; Heine B; Schindler I; Stein H; Berger G; Zeitz M; Scherübl H
    Virchows Arch; 2002 Sep; 441(3):256-63. PubMed ID: 12242522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
    Veras E; Deavers MT; Silva EG; Malpica A
    Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of patients with neuroendocrine carcinoma of the colon and rectum: a population-based analysis.
    Shafqat H; Ali S; Salhab M; Olszewski AJ
    Dis Colon Rectum; 2015 Mar; 58(3):294-303. PubMed ID: 25664707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staging of carcinoma of the colon and rectum.
    Roseman DL; Straus AK
    Surg Gynecol Obstet; 1980 Jul; 151(1):93-5. PubMed ID: 7384992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rectal and colonic carcinoids. A clinicopathologic study of 84 cases.
    Federspiel BH; Burke AP; Sobin LH; Shekitka KM
    Cancer; 1990 Jan; 65(1):135-40. PubMed ID: 2293859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of neuroendocrine carcinomas of the uterine cervix, including histopathologic features, terminology, immunohistochemical profile, and clinical outcomes in a series of 50 cases from a single institution in India.
    Rekhi B; Patil B; Deodhar KK; Maheshwari A; A Kerkar R; Gupta S; Tongaonkar HB; Shrivastava SK
    Ann Diagn Pathol; 2013 Feb; 17(1):1-9. PubMed ID: 22534245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine differentiation in "poorly differentiated" colon carcinomas.
    Staren ED; Gould VE; Jansson DS; Hyser M; Gooch GT; Economou SG
    Am Surg; 1990 Jul; 56(7):412-9. PubMed ID: 2368984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long term outcomes of neuroendocrine carcinomas (high-grade neuroendocrine tumors) of the colon, rectum, and anal canal.
    Aytac E; Ozdemir Y; Ozuner G
    J Visc Surg; 2014 Feb; 151(1):3-7. PubMed ID: 24412088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective multicenter trial of staging adequacy in colon cancer: preliminary results.
    Bilchik AJ; DiNome M; Saha S; Turner RR; Wiese D; McCarter M; Hoon DS; Morton DL
    Arch Surg; 2006 Jun; 141(6):527-33; discussion 533-4. PubMed ID: 16785352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical significance of neuroendocrine differentiation in T3-T4 node-negative colorectal cancer.
    Cho YB; Yang SS; Lee WY; Song SY; Kim SH; Shin HJ; Yun SH; Chun HK
    Int J Surg Pathol; 2010 Jun; 18(3):201-6. PubMed ID: 19372085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic significance of specific histologic features of carcinoma of the colon and rectum.
    de Mascarel A; Coindre JM; de Mascarel I; Trojani M; Marée D; Hoerni B
    Surg Gynecol Obstet; 1981 Oct; 153(4):511-4. PubMed ID: 7280939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine neoplasms of the lung. A clinicopathologic update.
    Warren WH; Faber LP; Gould VE
    J Thorac Cardiovasc Surg; 1989 Sep; 98(3):321-32. PubMed ID: 2549306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine differentiation in adrenocortical carcinoma. New immunohistochemical findings supported by electron microscopy.
    Miettinen M
    Lab Invest; 1992 Feb; 66(2):169-74. PubMed ID: 1735954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psammoma bodies in neuroendocrine carcinoma of the uterine cervix.
    Russin VL; Valente PT; Hanjani P
    Acta Cytol; 1987; 31(6):791-5. PubMed ID: 3425140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.